Severe obesity appears to be on the rise among young U.S. children, based on data from a federal supplemental nutrition program. About 2% of children between 2 and 4 years of age in the Women, Infants and Children (WIC) nutrition program were severely obese by 2020, a new study reports. That’s about 33,000 of the…  read on >  read on >

If you’re one of the 50 million Americans with asthma or allergies, 2024 is another year to redouble efforts to manage them. But how? “It’s not always easy to get allergies and asthma under control,” allergist Dr. Gailen Marshall, president of the American College of Allergy, Asthma and Immunology (ACAAI), said in a tip sheet…  read on >  read on >

Federal agents have seized more than 1.4 million illegal vaping products being smuggled into the United States from China. A three-day operation at Los Angeles International Airport resulted in the seizure of 41 shipments of illegal e-cigarettes worth more than $18 million, the U.S. Food and Drug Administration said. The products included the hugely popular…  read on >  read on >

Knives, vegetable peelers, blenders: There are plenty of ways to injure yourself in the kitchen during the holidays. To keep things merry, cheery and safe, experts at Midwest Orthopaedics at RUSH (MOR) in Chicago say there are simple steps you and those who are helping you cook can take to stay safe. They point out…  read on >  read on >

Media mogul Oprah Winfrey confirmed Wednesday that she has used a weight-loss medication to help her shed pounds and get healthy. Winfrey has added the drug to a regimen that includes regular exercise and other lifestyle tweaks, People magazine reported. Weight fluctuations “occupied five decades of space in my brain, yo-yoing and feeling like why…  read on >  read on >

A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD). When announcing the new drug application (NDA) filing on Tuesday, MAPS Public Benefit Corp. noted it has been studying the drug for this…  read on >  read on >